First off: Dabur Pharma plans $25mn QIP

Ds to qualified institutional buyers (QIBs) in terms of SEBI Guidelines for Qualified Institutional Placement (QIP).

According to a release issued by Dabur Pharma to the BSE today, the meeting also recommended a dividend of 20% on equity shares to shareholders.